Feizhou Zhu

761 citations
15 papers · 490 indexed · 1 hit paper · h-index 7
Topics
Cancer, Hypoxia, and Metabolism (4 papers)Adrenal and Paraganglionic Tumors (4 papers)Multiple Sclerosis Research Studies (2 papers)
Journals
SHILAP Revista de lepidopterologíaOncotargetInternational Journal of Nanomedicine
Partner nations
ChinaZimbabwe

In The Last Decade

Feizhou Zhu

15 papers receiving 483 citations

Hit Papers

<p>Antibacterial activity and mechanism of silver nanopar...20192026202120232019100200300

Peers

Feizhou Zhu
Comparison fields: 5 of 89
  • Materials Chemistry 226
  • Biomedical Engineering 135
  • Molecular Biology 121
  • Food Science 50
  • Organic Chemistry 38
Replace Ranjit K. Mehta with:
Ranjit K. Mehta United States
İlknur Dağ Türkiye
Dakshayani Lomada India
Šárka Hradilová Czechia
Paramanantham Parasuraman India
Amr T. M. Saeb Saudi Arabia
Ji-Sook Hahn South Korea
Sourabh Mehta India
V. T. Anju India
Sathiamoorthi Thangavelu India
Feizhou Zhu relative to Ranjit K. Mehta United States Ranjit K. Mehta's profile →
Citations per field
00.5×1.5×
Ranjit K. Mehta · 1×
Citations per year

Countries citing papers authored by Feizhou Zhu

Since Specialization
Citations

This map shows the geographic impact of Feizhou Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feizhou Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feizhou Zhu more than expected).

Fields of papers citing papers by Feizhou Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feizhou Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feizhou Zhu. The network helps show where Feizhou Zhu may publish in the future.

Co-authorship network of co-authors of Feizhou Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Feizhou Zhu. A scholar is included among the top collaborators of Feizhou Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feizhou Zhu. Feizhou Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 9
2 8
3 6
4 5
5 4
6
<p>Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant <em>Pseudomonas aeruginosa</em></p>breakdown →
372
7 11
8 8
9 14
10 1
11 2
12 44
13 1
14 1
15
An overview of the molecular assaying methods for transgenic plants
4

About Feizhou Zhu

Feizhou Zhu is a scholar working on Periodontics, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 15 papers that have together received 490 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Adrenal and Paraganglionic Tumors (4 papers) and Multiple Sclerosis Research Studies (2 papers). The work is most often cited by research in Materials Chemistry (226 citations), Molecular Medicine (19 citations) and Complementary and alternative medicine (28 citations). Feizhou Zhu has collaborated with scholars based in China and Zimbabwe. Frequent co-authors include Qianqian Liu, Liyu Chen, Yapeng Zhang, Gan Dai, Linqian Wang, Zhongyi Cheng, Guojun Wu, Md. Asaduzzaman Khan, Weilong Liu and Lu Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Oncotarget and International Journal of Nanomedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026